WideCells Group

WideCells Dr. Marilyn Orcharton Attends BDA Conference 2017

WideCells Group (‘WideCells’ or ‘the Company’) Attendance at British Dental Conference and Exhibition WideCells Group PLC ('WideCells' or the 'Company'), the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is pleased to announce that Non-Executive Director Dr. Marilyn Orcharton will be representing the Company at the upcoming British Dental Conference and Exhibition, being held in Manchester from 25-27 May 2017.  At the conference, Dr. Orcharton will be providing information on the Company’s plans to extend its stem cell storage services to include dental pulp storage and processing (TeethCells).  The Company hopes to start offering this new service to the market in the coming months and, having recognised significant growth opportunities within the dental industry, intends to appoint a Dental Key Account Manager to manage this emerging revenue stream including potential strategic relationships with distribution partners in Europe and the Middle-East. Dr. Orcharton is a renowned figure in dentistry, having co-founded Denplan Limited in 1986, which is still the UK's market leader in dental insurance, with a multi-million-pound annual turnover.   WideCells is looking to achieve similar success in the stem cell industry via its CellPlan division, which is rolling out the world’s first stem cell healthcare insurance plan.    

Attendance at Brazilian Obstetrics and Gynaecology Conference

WideCells Group PLC ('WideCells' or the 'Company'), the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is pleased to announce its attendance at the Obstetrics and Gynaecology Conference in São Paulo, Brazil, 25-26 May 2017.  At the conference, Dr Niranjan Bhattacharya, a preeminent figure in the stem cell industry and founding member of CellPlan’s Stem Cell Panel, will be making a presentation on stem cell technology and the developments both he and WideCells are driving within the industry.   

Annual Report and Accounts 2016 & AGM

2 May 2017 WideCells Group PLC (‘WideCells Group’ or ‘the Company’)  Annual Report and Accounts for the year ended 31 December 2016 and Notice of Annual General Meeting WideCells Group PLC (‘WideCells’ or the ‘Company’), the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, announces that its Annual Report and Accounts for the year ended 31 December 2016 and a Notice of Annual General Meeting (“AGM”) have been posted to shareholders and are available to download on the Company’s website at http://www.widecellsgroup.com/. The AGM will be held on 22 June 2017 at the Core Technology Facility, 46 Grafton Street, Manchester, M13 9NT at 12.00 noon. **ENDS**

WideCells

Expansion placement completed

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is pleased to announce that it has raised gross proceeds of £648,696 by way of a private placing (the ‘Placing’). 

Preliminary results

WideCells Group PLC Unaudited Preliminary Results

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, announces its unaudited preliminary results for the period ended 31 December 2016. 

Former Director of Education at Apple Joins Board to Grow WideAcademy

WideCells Group, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is delighted to announce the appointment of former Director of Education at Apple, Mr. Alan Greenberg, to the Board as Non-Executive Director and Vice President (‘VP’) of WideAcademy, WideCells Group’s research and development (‘R&D’) and training division.

wideCel

WideCells Group PLC Director Purchases and Grant of Options

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is pleased to announce that Chairman  Dr.  Graham Hine, Chief Executive Officer João Andrade, Chief Financial Officer David Bridgland, Chief Operating Officer Lopes Gil and Non-Executive Director Marilyn Orcharton have purchased a combined total of 100,000 new ordinary shares in the Company (the 'Director Purchases').

WideCells Group PLC Grant of Options

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, announces that on 24 January 2017 the Company granted options ("Options") over 600,000 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's EMI Share Option Plan, and 270,290 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's 2017 Share Option Plan For Consultants And Non-Executive Directors.  These Options were granted to Persons Discharging Managerial Responsibilities ("PDMRs") on behalf of the Company.

CellPlan Logo

WideCells Group PLC Secures two LOIs for CellPlan

WideCells Group PLC, the healthcare services company focused on providing stem cell services and  ground breaking  insurance for stem cell treatment, is pleased to provide an update on the continued commercialisation of its 100% owned subsidiary CellPlan Limited (‘CellPlan’), which has developed the world's first stem cell  healthcare  insurance plan and medical concierge service.  Having recently secured a maiden definitive agreement with Biovault Technical Ltd, the UK's largest private human tissue storage facility (‘Biovault’), to roll-out CellPlan to Biovault’s significant customer base (see announcement dated 9 January 2017), the Company is delighted to have signed two further non-binding Letter of Intent ('LOI') agreements to support the continued roll-out of CellPlan globally.  The Company has also developed a new commercial CellPlan product, YOUR EXPERT CONSULTATION, further bolstering CellPlan’s innovative service offering and creating a new revenue opportunity.

Definitive Agreement to Roll Out CellPlan to Customers of Cord Blood Store

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is pleased to announce that, further to its announcement released on 7 November 2016, its 100% owned subsidiary CellPlan Limited (‘CellPlan’), which has developed the world's first stem cell healthcare insurance plan and medical concierge service, has cemented its agreement with Biovault Technical Ltd (‘Biovault’) via a definitive agreement, which covers an initial five-year term.

WideCells Group PLC webs

WideCells Group signs LOI with medical device company

WideCells Group PLC signs LOI with medical device company to undertake stem cell research at WideCells’ Manchester Institute of Stem Cell Technology

WideCells Group PLC Signs LOI with First Cord Blood Bank

CellPlan Limited (‘CellPlan’), which has developed the world's first stem cell healthcare insurance plan and medical concierge service, has signed a non-binding Letter of Intent (‘LOI’) with Biovault Technical Ltd. 

Corporate Update - 24.10.2016

Recognising the instrumental role a highly skilled team will play in delivering on its strategic vision, the Group has made additional key personnel appointments across its three core divisions

Update on CellPlan - An innovative Stem Cell Insurance Plan

WideCells Group PLC, the healthcare services company focused on providing stem cell banking services and ground breaking insurance for stem cell treatment, is pleased to announce that it has finalised the terms and conditions for CellPlan, the world’s first stem cell healthcare insurance plan and medical concierge service, which was launched to cord blood banks in May 2016 at the World Cord Blood Congress in London.  

WideCells Group PLC Partner With University of Westminster

WideCells Group PLC  is pleased to announce that its R&D and training development division, WideAcademy, has finalised its syllabus of short courses focused on educating healthcare professionals on the benefits of stem cell storage and treatment.

Update on Manchester Facility and Appointments

WideCells Group, the healthcare services company focused on collecting and storing stem cells and providing ground breaking insurance for stem cell treatment, is pleased to announce...

P

WideCells Group PLC Publication of Prospectus

WideCells Group PLC Publication of Prospectus